APLCC 2012: Interim GALAXY Phase 2b lung cancer study results to be presented

[News]

Synta Pharmaceuticals Corp. announced today that interim results of the Phase 2b portion of the GALAXY program will be presented on November 28, 2012 at 12:15 p.m. (JST) during the "Highlights of Oral Presentations" session at the Fifth Asia Pacific Lung Cancer Conference (APLCC 2012) in Fukuoka City, Japan.

More... (http://www.news-medical.net/news/20121126/APLCC-2012-Interim-GALAXY-Phase-2b-lung-cancer-study-results-to-be-presented.aspx)